Formulation of patient dose of 177Lu-DOTA-TATE in hospital radiopharmacy in India: preparation using in situ methodology vis-a-vis freeze-dried kit
dc.contributor.author | Das, T. | |
dc.contributor.author | Banerjee, S. | |
dc.date.accessioned | 2015-09-01T09:35:32Z | |
dc.date.available | 2015-09-01T09:35:32Z | |
dc.date.issued | 2014 | |
dc.description.division | RC&IG | en |
dc.format.extent | 3323 bytes | |
dc.format.mimetype | text/html | |
dc.identifier.source | Cancer biotherapy & radiopharmaceuticals, 2014. Vol. 29 (7): pp. 301-302 | en |
dc.identifier.uri | http://hdl.handle.net/123456789/11615 | |
dc.language.iso | en | en |
dc.subject | patient dose | en |
dc.subject | 177Lu-DOTA-TATE | en |
dc.subject | hospital radiopharmacy | en |
dc.subject | India | en |
dc.subject | in situ methodology vis-a-vis freeze-dried kit | en |
dc.title | Formulation of patient dose of 177Lu-DOTA-TATE in hospital radiopharmacy in India: preparation using in situ methodology vis-a-vis freeze-dried kit | en |
dc.type | Article | en |